144 related articles for article (PubMed ID: 19880876)
1. Exercise training as a treatment for heart failure: potential mechanisms and clinical implications.
Benito B; Nattel S
J Physiol; 2009 Nov; 587(Pt 21):5011-3. PubMed ID: 19880876
[No Abstract] [Full Text] [Related]
2. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
[TBL] [Abstract][Full Text] [Related]
3. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
Kreusser MM; Lehmann LH; Keranov S; Hoting MO; Oehl U; Kohlhaas M; Reil JC; Neumann K; Schneider MD; Hill JA; Dobrev D; Maack C; Maier LS; Gröne HJ; Katus HA; Olson EN; Backs J
Circulation; 2014 Oct; 130(15):1262-73. PubMed ID: 25124496
[TBL] [Abstract][Full Text] [Related]
4. Different roles of BAG3 in cardiac physiological hypertrophy and pathological remodeling.
Jia P; Wu N; Yang H; Guo Y; Guo X; Sun Y
Transl Res; 2021 Jul; 233():47-61. PubMed ID: 33578031
[TBL] [Abstract][Full Text] [Related]
5. Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations.
Noh J; Wende AR; Olsen CD; Kim B; Bevins J; Zhu Y; Zhang QJ; Riehle C; Abel ED
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):297-305. PubMed ID: 26476238
[TBL] [Abstract][Full Text] [Related]
6. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
7. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
8. TRPC1 channels are critical for hypertrophic signaling in the heart.
Seth M; Zhang ZS; Mao L; Graham V; Burch J; Stiber J; Tsiokas L; Winn M; Abramowitz J; Rockman HA; Birnbaumer L; Rosenberg P
Circ Res; 2009 Nov; 105(10):1023-30. PubMed ID: 19797170
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
[TBL] [Abstract][Full Text] [Related]
10. Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice.
Bacurau AV; Jannig PR; de Moraes WM; Cunha TF; Medeiros A; Barberi L; Coelho MA; Bacurau RF; Ugrinowitsch C; Musarò A; Brum PC
Int J Cardiol; 2016 Jul; 214():137-47. PubMed ID: 27060274
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cardiac hypertrophy by intracellular signalling pathways.
Heineke J; Molkentin JD
Nat Rev Mol Cell Biol; 2006 Aug; 7(8):589-600. PubMed ID: 16936699
[TBL] [Abstract][Full Text] [Related]
12. Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling.
Davis RT; Simon JN; Utter M; Mungai P; Alvarez MG; Chowdhury SA; Heydemann A; Ke Y; Wolska BM; Solaro RJ
Cardiovasc Res; 2015 Dec; 108(3):335-47. PubMed ID: 26464331
[TBL] [Abstract][Full Text] [Related]
13. Harbingers of hypertrophy and heart failure.
Luft FC
J Mol Med (Berl); 2004 Oct; 82(10):635-7. PubMed ID: 15372167
[No Abstract] [Full Text] [Related]
14. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training.
Bacurau AV; Jardim MA; Ferreira JC; Bechara LR; Bueno CR; Alba-Loureiro TC; Negrao CE; Casarini DE; Curi R; Ramires PR; Moriscot AS; Brum PC
J Appl Physiol (1985); 2009 May; 106(5):1631-40. PubMed ID: 19179649
[TBL] [Abstract][Full Text] [Related]
15. Signaling path may lead to better heart-failure therapies.
Barinaga M
Science; 1998 Apr; 280(5362):383. PubMed ID: 9575084
[No Abstract] [Full Text] [Related]
16. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
17. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
[TBL] [Abstract][Full Text] [Related]
18. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
19. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
[TBL] [Abstract][Full Text] [Related]
20. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
